RG6042 (RO7234292)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RG6042 (RO7234292), covering 2024-10-03 to 2024-10-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Pharmacokinetics and Pharmacodynamics of RO7234292 (RG6042) in CSF and Plasma, and Safety and Tolerability Following Intrathecal Administration in Patients With Huntington's Disease [Phase 1]